代谢功能障碍女性脂肪组织中雄激素分解代谢与芳香化作用指标升高
研究纳入40例重度肥胖减重手术候选者(31例女性,9例男性),检测内脏与皮下脂肪组织类固醇浓度及酶活性。女性内脏脂肪芳香化酶活性与脂肪细胞肥大正相关(P值校正后<0.01)、与血浆高密度脂蛋白胆固醇负相关(P值校正后<0.01),皮下脂肪芳香化酶活性可预测血脂异常;高内脏脂肪指数女性表现为脂肪组织功能障碍、AKR1C2活性升高的雄激素分解代谢增强及芳香化酶表达与活性指标升高。
要点
- 女性内脏脂肪芳香化酶活性与内脏脂肪细胞肥大正相关(P值校正后<0.01)。
- 女性内脏脂肪芳香化酶活性与血浆高密度脂蛋白胆固醇负相关(P值校正后<0.01)。
- 女性皮下脂肪芳香化酶活性可预测血脂异常,校正腰围、年龄和激素避孕药使用后仍成立。
核心结论
- 在女性中,雄激素分解代谢或芳香化作用增强与内脏肥胖及脂肪组织功能障碍相关。
研究设计与样本
- 研究纳入40例减重手术候选者(31例女性,9例男性),术中采集内脏脂肪组织(VAT)和皮下脂肪组织(SAT)样本。
- 脂肪组织形态通过组织学染色与半自动量化结合测定;脂肪组织内和血浆类固醇浓度通过液相色谱-电喷雾电离串联质谱(LC-ESI-MS/MS)测定。
- 芳香化酶活性通过产物与底物比值估算,AKR1C2活性通过荧光探针直接测定,基因表达通过定量PCR测定。
主要发现
- 女性VAT芳香化酶活性与VAT脂肪细胞肥大正相关(P值校正后<0.01),与血浆高密度脂蛋白(HDL)胆固醇负相关(P值校正后<0.01)。
- 女性SAT芳香化酶活性可预测血脂异常,即使校正腰围、年龄和激素避孕药使用后仍成立。
- 比较女性高与低内脏脂肪指数(VAI)组,VAT过量表现为脂肪组织功能障碍、AKR1C2活性升高的雄激素分解代谢增强以及芳香化酶表达和活性指标升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Body fat distribution is a risk factor for obesity-associated comorbidities, and adipose tissue dysfunction plays a role in this association. In humans, there is a sex difference in body fat distribution, and steroid hormones are known to regulate several cellular processes within adipose tissue. OBJECTIVE: Our aim was to investigate if intra-adipose steroid concentration and expression or activity of steroidogenic enzymes were associated with features of adipose tissue dysfunction in individuals with severe obesity. METHODS: Samples from 40 bariatric candidates (31 women, 9 men) were included in the study. Visceral (VAT) and subcutaneous adipose tissue (SAT) were collected during surgery. Adipose tissue morphology was measured by a combination of histological staining and semi-automated quantification. Following extraction, intra-adipose and plasma steroid concentrations were determined by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). Aromatase activity was estimated using product over substrate ratio, while AKR1C2 activity was measured directly by fluorogenic probe. Gene expression was measured by quantitative PCR. RESULTS: VAT aromatase activity was positively associated with VAT adipocyte hypertrophy (P valueadj < 0.01) and negatively with plasma high-density lipoprotein (HDL)-cholesterol (P valueadj < 0.01), while SAT aromatase activity predicted dyslipidemia in women even after adjustment for waist circumference, age, and hormonal contraceptive use. We additionally compared women with high and low visceral adiposity index (VAI) and found that VAT excess is characterized by adipose tissue dysfunction, increased androgen catabolism mirrored by increased AKR1C2 activity, and higher aromatase expression and activity indices. CONCLUSION: In women, increased androgen catabolism or aromatization is associated with visceral adiposity and adipose tissue dysfunction.
引用
- Ostinelli G, Laforest S, Denham SG, et al. Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction. J Clin Endocrinol Metab. 2022. PMID: 35511873. doi:10.1210/clinem/dgac261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。